News has it that Gilead Sciences, Inc. (NASDAQ:GILD) is looking forward to sealing an acquisition deal with Arrowhead Research Corp…
Gilead Sciences (NASDAQ:GILD) is rolling high these days. The company has become an advertisement of success. Gilead launched its new…
On December 9, the Southern Pennsylvania Transportation Society (SEPTA) filed a lawsuit against Gilead Sciences (NASDAQ:GILD) stating that the company…
It has been almost 2 years since AbbVie (NYSE:ABBV) and Zoetis (NYSE:ZTS) got separated from Abbot Labs (NYSE:ABT) and Pfizer…
It isn’t surprising when we get to hear about fluctuating dips in the pharmaceutical industry. Gilead Sciences (NASDAQ:GILD)’s stock, which…
Sovaldi is perhaps one of the most lucrative drugs of the 21st century. Surely, the drug, which is necessary for…